This announcement is a separate document:
中國抗體-B:關連交易 - 建議發行100,000,000港元於二零二二年到期的可換股債券可能根據特別授權發行股份
SINOMAB BIO-B: CONNECTED TRANSACTION -PROPOSED ISSUE OF HK$100,000,000 CONVERTIBLE BONDS DUE 2022POSSIBLE ISSUE OF SHARES UNDER SPECIFIC MANDATE
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.